Trillium Meds advertises GLP-1 plans "from $109" per month, but public evidence doesn't show whether that figure is month-to-month or a prepaid equivalent—or which medication it applies to. Without a documented plan grid, we can't calculate which option costs less.

Trillium Meds advertises compounded GLP-1 from $109/month, but the full pricing structure—refill rates, dose tiers, and billing terms—is not publicly itemized. We show what's known, what's missing, and how PlexusDx compares where evidence allows.

Trillium Meds advertises GLP-1 programs from $109/month, but tirzepatide-specific pricing, dose tiers, route, and plan structure are not disclosed publicly as of September 2026.

Trillium Meds advertises GLP-1 plans from $109, but the ongoing rate, route, and full pricing structure are not publicly itemized. We compare the available evidence against PlexusDx's verified tiered pricing and explain what questions to resolve before you decide.

Trillium Meds advertises plans from $109/month, but transfer logistics, medication routes, and cancellation policies remain undocumented in public sources. Here's what the evidence shows—and what you should confirm—before switching to PlexusDx.

Trillium Meds advertises a $109/month starting rate, but the medication, route, and ongoing cost remain undisclosed publicly. PlexusDx publishes a full pricing grid with no promotional tiers, beginning at $129/month for microdose GLP-1 and $189/month for semaglutide injection.